Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03010982 |
|---|---|
| Brief Title: | Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors |
| First Submitted : | December 19, 2016 |
| First Submitted that Met QC Criteria : | January 3, 2017 |
| First Posted : | January 5, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 8, 2020 |
| Last Update Posted : | January 13, 2020 |